Find Unlimited Emails.For Free.

Discover prospects, find their business emails, and build your pipeline with Unifers.

Start for Free

Sebastian Patzke

Senior Scientist Project Manager @Spinchip Diagnostics As A Biomérieux Company

Oslo, NO
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Sep 2023 — Present

Senior Scientist Project Manager @Spinchip Diagnostics As A Biomérieux Company

Oslo, NO

Senior scientist / Project manager reporting to SVP Assay development- Working with cross-functional team on expanding the assay portfolio for SpinChip\'s state-of-the-art high-sensitivity in-vitro diagnostics platform for point-of-care use

EDUCATION

1992 — 1998

Technische Universität Berlin

Dipl.Ing., Biotechnology

2019 — 2019

University of Oslo

certificate, Health innovation and entrepreneurship; School of Health Innovation and Entrepreneurship

2002 — 2006

University of Oslo

PhD, Cancer Research, Immunology

SKILLS

Molecular GeneticsGeneticsCell CultureCellProtein ChemistryWestern BlottingLifesciencesImmunologyCancerFlow CytometryMicroscopyQpcrConfocal MicroscopyLife SciencesEnglishMolecular BiologyPcrCancer ResearchMolecular CloningCell Biology

ABOUT SEBASTIAN PATZKE

Notoriously curious academically and industrially trained scientist & project manager combining deep understanding of molecular mechanism underlying human development and disease with broad technology insights, strategic thinking and team leadership to define & deliver on ambitious company goals Current role: Senior Scientist / Project manager at SpinChip Diagnostics, reporting to SVP Assay Development. Expanding with cross-functional team the high-sensitivity in-vitro diagnostic assay portfolio for SpinChip’s newly developed rapid point-of-care instrument. Previous role: Head of Discovery at Nordic Nanovector working on development of targeted alpha-particle emitter-based pharmaceuticals, reporting to CSO. Delivering with small R&D team and CROs on identification and evaluation of new candidate targets for radioimmunotherapy of metastasized solid tumor indications. Responsible for project management and implementation, including bioinformatic identification and independent validation of candidate targets; development and optimization of candidate drugs, experiment planning/reviewing/reporting. Working with CSO on project plan development, MVP, supply-chain/CRO resourcing, KOL interactions, collaborations, and presentations for internal and external stakeholders. Building on previous employment at Nordic Nanovector as Research manager (3 yrs, member of Extended leadership team), leading projects on identification and abrogation of resistance mechanisms to Lutetium-177 based radioimmunotherapy in B cell lymphoma.>20 years of experience in academic cancer research with primary focus on therapeutically exploitable molecular mechanisms underlying malignant transformation, disease progression, and treatment resistance, as well as pre-clinical development of targeted radiotherapeutics. Recipient of several competitive personal fellowships and research grants.Latest academic role: independent Project Group Leader (Ass-professor competent), in which I formed cross-functional teams and interdisciplinary research networks with internationally leading experts to understand key molecular mechanism that are affected in developmental disease and cancer for innovative therapies. Supervisor of PhD/Master students & research personnel, publication & presentation of results and strategies to different stakeholders/audiences. Reviewer for international journals and funding agencies.>30 primary research publications, whereof several in highly reputed journals. Linguistically proficient in German (native), English (fluent), and Norwegian (fluent).

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.